Skip banner and top navigation
NHLBI Logo and Link
National Heart, Lung, and Blood Institute: People, Science, Health
 TEXT SIZE: 
 HOME  SITE INDEX  CONTACT US
  
About NHLBI
Link to the National Institutes of Health Link to the Department of Health and Human Services
Skip left side navigation and go to content
 NHLBI Home
 Information for Patients & the Public
 Information for Health Professionals
 Information for Researchers
 Funding, Training, & Policies
 Clinical Trials
 Networks & Outreach
 News & Events Center
 About NHLBI

NHLBI Organization

The Director's Page

Overview & Planning Documents

Advisory and Peer Review Committees

Budget and Legislative Information

The National Cholesterol Education Program (NCEP)
National Heart, Lung, and Blood Institute
Coordinating Committee Meeting

October 16, 2001
Marriott Tysons Corner
Vienna, Virginia

HIGHLIGHTS

  • Dr. David Orloff reported on research and results relating to the possibility of statin drugs causing rhabdomyolysis. Data from the studies showed that cerivastatin carried a significantly higher risk of rhabdomyolysis than do the other statins, especially when used in combination with gemfibrozil. He stressed that results of at least five major trials demonstrate that statins reduce morbidity and mortality from coronary heart disease and are generally safe.

  • Dr. James Cleeman reported on activities to promote the adoption of ATP III. This has included publishing the ATP III Executive Summary in the Journal of the American Medical Association, holding a press conference, and extensive media coverage. Tools and materials to speed up the implementation of the guidelines have been developed and posted on the NHLBI's ATP III Web page (http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm). These tools and materials include a patient brochure, the "Guidelines At-A Glance Quick Desk Reference," online 10-year risk calculators, an interactive guideline tool for Palm OS, and PowerPoint slides. The NCEP also cosponsored a national conference with the National Committee for Quality Assurance (NCQA) to assist in the implementation of the new guidelines.

  • Drs. Scott Grundy, Stephen Havas, and Lewis Kuller presented the issue of reducing lifetime CHD risk in the individual at low short-term risk. They contrasted population-based approaches with medical high-risk approaches, noting benefits and drawbacks of both. They agreed that a population-based approach would be a good idea at this time.

  • The Coordinating Committee members broke into small discussion groups to consider aspects of a possible population-based campaign to reduce cholesterol. They reconvened and expressed a consensus to move forward with such a plan.

Skip footer links and go to content

HOME · SEARCH · ACCESSIBILITY · SITE INDEX · OTHER SITES · PRIVACY STATEMENT · FOIA · CONTACT US